Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New Immunosuppressive Cell Therapy to Prolong Survival of Induced Pluripotent Stem Cell-Derived Allografts.

Transplantation - 1 Nov 2015

Sasaki Hajime, Wada Haruka, Baghdadi Muhammad, Tsuji Hyuma, Otsuka Ryo, Morita Ken, Shinohara Nobuo, Seino Ken-Ichiro

Abstract excerpt

BACKGROUND: Induced pluripotent stem cell (iPSC) technology provides new opportunities in regenerative medicine to generate grafts from donors for transplantation. However, particularly when allogeneic iPSCs are used, immune suppression is required to avoid rejection of iPSC-derived grafts. In this study, we examine a concept that protection of iPSCs-derived allografts can be achieved when transplantation is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Allografts
Share to Coculture Techniques

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Graft Rejection

Share to Graft Survival

Share to Immunosuppression Therapy

Share to Isoantibodies

Share to Myeloid Cells

Share to Nitric Oxide Synthase Type II

Source

Identifiers

PMID: 26360665
DOI: 10.1097/TP.0000000000000875

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New Immunosuppressive Cell Therapy to Prolong Survival of Induced Pluripotent Stem Cell-Derived Allografts.PMID 26360665Read ↗

Induction of macrophage-like immunosuppressive cells from mouse ES cells that contribute to prolong allogeneic graft survival.Semantic proximity Read ↗

Advancements and Innovative Strategies in Induced Pluripotent Stem Cell‐Derived Mesenchymal Stem Cell Therapy: A Comprehensive ReviewSemantic proximity Read ↗

Induction of macrophage-like immunosuppressive cells from common marmoset ES cells by stepwise differentiation with DZNep.Semantic proximity Read ↗

Immunomodulatory Properties of Induced Pluripotent Stem Cell‐Derived Mesenchymal CellsSemantic proximity Read ↗

iPSC modification strategies to induce immune toleranceSemantic proximity Read ↗

Immunomodulation by Mesenchymal Stem CellsSemantic proximity Read ↗

Concise Review: Immunomodulatory Properties of Mesenchymal Stem Cells in Cellular Transplantation: Update, Controversies, and UnknownsSemantic proximity Read ↗

New concepts on the immune modulation mediated by mesenchymal stem cellsSemantic proximity Read ↗

Therapeutic potential of the immunomodulatory activities of adult mesenchymal stem cellsSemantic proximity Read ↗

Induction of long-term allogeneic cell acceptance and formation of immune privileged tissue in immunocompetent hostsSemantic proximity Read ↗

Differentiation of Mesenchymal Stem Cells from Human Induced Pluripotent Stem Cells Results in Downregulation of c-Myc and DNA Replication Pathways with Immunomodulation Toward CD4 and CD8 CellsSemantic proximity Read ↗

Adaptation of Human iPSC-Derived Macrophages Toward an Alveolar Macrophage-Like Phenotype Post-Intra-Pulmonary Transfer into Murine Models.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.